[Antiproteolytic activity of the blood serum in adolescents with pulmonary tuberculosis].
The antiproteolytic activity of the blood serum was examined in the course of hospital treatment of 128 adolescents with prevailingly torpid forms of pulmonary tuberculosis and in 19 adolescents with tubercular infection (control). A direct correlation has been found between the degree of clinico-roentgenological manifestations of the disease and level of serum alpha 1-inhibitor of proteinases as well as between the efficacy of treatment and normalization of the antiproteolytic activity of the blood of the patients. It proposed to use the determination of alpha 1-inhibitor of proteinases as an additional criterion of evaluation of the clinical course and outcomes of the disease in adolescents.
Il'nitskiĭ
I G
IG
Rushchak
V A
VA
Kunichkina
S A
SA
Blizniuk-Khodorovskaia
O I
OI
Zholob
V V
VV
D000293:Adolescent; D000995:Antitubercular Agents / Q000627:therapeutic use; D001798:Blood Proteins / Q000032:analysis; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D011480:Protease Inhibitors / Q000097:blood*; D014375:Tuberculoma / Q000097:blood / Q000188:drug therapy; D014388:Tuberculosis, Lymph Node / Q000097:blood / Q000188:drug therapy; D014391:Tuberculosis, Miliary / Q000097:blood / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000097:blood* / Q000188:drug therapy; D000515:alpha 1-Antitrypsin
D000995:Antitubercular Agents; D001798:Blood Proteins; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin
Antiproteoliticheskaia aktivnost' syvorotki krovi u podrostkov, bol'nykh tuberkulezom legkikh.